Abstract
Transglutaminases are at least nine enzymes that crosslink a number of proteins. This type of reaction not only enhances or abolishes the original functions of substrate proteins but adds new functions to them. Factor XIII, a plasma transglutaminase circulating in blood as a heterotetramer, consists of two catalytic A subunits and two noncatalytic B subunits. It is a proenzyme to be activated by thrombin in the blood coagulation cascade. It plays an important role(s) in hemostasis, wound healing, and maintenance of pregnancy. Accordingly, a lifelong bleeding tendency, abnormal wound healing, and recurrent spontaneous miscarriage are common symptoms of factor XIII deficiency. Genetic and molecular mechanisms of congenital deficiencies have been analyzed in vitro. The mechanisms of these defects have also been studied in detail using factor XIII gene knockout (KO) mice in vivo. The factor XIII KO mice of either the A or B subunit demonstrated unforeseen cardiac pathologies only in males. Acquired factor XIII deficiency is not uncommon, and one must pay attention to it. Recently, meta-analyses have indicated that the Val34Leu polymorphism of FXIII-A is associated with thrombosis. Emerging data suggest that in addition to its extracellular role in hemostasis FXIII-A may function as a cellular transglutaminase and be involved in certain intracellular processes that include cytoskeletal remodeling and signal transduction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.